Abstract
The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases.
| Translated title of the contribution | 調控物及含有該調控物之醫藥組合物 |
|---|---|
| Original language | English |
| Patent number | 9180139 |
| Publication status | Published - 2014 Feb 20 |